2-anilino-4-(heterocyclic)amino-pyrimidi nes as inhibitors of protein kinase Calpha

Details for Australian Patent Application No. 2007257650 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Golebiowski, Adam; Djung, Jane FarJine; Hunter, Jack A.; Shrum, Gary P.

Agent Davies Collison Cave

Pub. Number AU-A-2007257650

PCT Pub. Number WO2007/146981

Priority 60/813,956 15.06.06 US

Filing date 13 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/146981 Priority application(s): WO2007/146981

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257652-Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury

2007257649-Compositions to protect against fire action and advance in various surfaces, manufacturing and application process thereof